Randolph MarshallGuestDoes carotid revascularization improve cognitive outcomes in patients with carotid stenosis causing hemodynamic insufficiency? Can artificial intelligence predict the future risk of atrial fibrillation and stroke with markers derived from coronary artery calcium scans? And finally, what is the role of carotid disease in atrial fibrillation-associated breakthrough ischemic stroke? We'll tackle these questions in today's podcast, answer a few, and create a lot more.
[on-hold music]
I'm a professor of neurology at the University of Miami Miller School of Medicine and your host for the monthly Stroke Alert podcast.
We begin the June 2026 issue of the podcast on the heels of the recently presented late-breaking science at the 2026 European Stroke Organization Conference in Maastricht, Netherlands.
This year's meeting brought together thousands of stroke clinicians and researchers from around the world and showcased new data spanning acute intervention, secondary prevention, and recovery science.
Over the next few episodes of the podcast, we're going to dive deeply into many of these trials individually.
But today, I just want to give us some update, touch on some of the big themes, and the studies that generated the most hallway conversation.
Read the full transcript.
Create an account to read the whole episode, search across every transcript, and follow the shows you care about.
Does carotid revascularization improve cognitive outcomes in patients with carotid stenosis causing hemodynamic insufficiency? Can artificial intelligence predict the future risk of atrial fibrillation and stroke with markers derived from coronary artery calcium scans? And finally, what is the role of carotid disease in atrial fibrillation-associated breakthrough ischemic stroke? We'll tackle these questions in today's podcast, answer a few, and create a lot more.
[on-hold music]
I'm a professor of neurology at the University of Miami Miller School of Medicine and your host for the monthly Stroke Alert podcast.
We begin the June 2026 issue of the podcast on the heels of the recently presented late-breaking science at the 2026 European Stroke Organization Conference in Maastricht, Netherlands.
This year's meeting brought together thousands of stroke clinicians and researchers from around the world and showcased new data spanning acute intervention, secondary prevention, and recovery science.
Over the next few episodes of the podcast, we're going to dive deeply into many of these trials individually.
But today, I just want to give us some update, touch on some of the big themes, and the studies that generated the most hallway conversation.